dc.contributor.author |
Stiller, Ibolya |
|
dc.contributor.author |
Lizák, Beáta |
|
dc.contributor.author |
Bánhegyi, Gábor |
|
dc.date.accessioned |
2017-06-12T12:39:26Z |
|
dc.date.available |
2017-06-12T12:39:26Z |
|
dc.date.issued |
2014 |
|
dc.identifier |
84925859747 |
|
dc.identifier.citation |
pagination=1019-1025;
journalVolume=15;
journalIssueNumber=11;
journalTitle=CURRENT PHARMACEUTICAL BIOTECHNOLOGY; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/3414 |
|
dc.identifier.uri |
doi:10.2174/1389201015666141122204139 |
|
dc.description.abstract |
Presenilin (PS) was identified in screens for mutations causing the early onset forms of familial Alzheimer's disease (FAD) in 1995. As catalytic units of the gamma-secretase complex, presenilins participate in the processing of amyloid beta protein (Abeta), the main component of deposits in brain of patients with AD. The more than 90 substrates of gamma-secretase isolated so far demonstrate its contribution to wide range of cellular processes and signaling events. However, recent findings have revealed numerous gamma-secretase-independent presenilin functions, including involvement in calcium homeostasis, endoplasmic reticulum (ER) stress and autophagy. This mini-review attempts to summarize the multiple physiological and pathological functions of presenilin. |
|
dc.relation.ispartof |
urn:issn:1389-2010 |
|
dc.title |
Physiological Functions of Presenilins; Beyond gamma-Secretase. |
|
dc.type |
Journal Article |
|
dc.date.updated |
2016-05-30T14:24:15Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
2806677 |
|
dc.identifier.wos |
000345683800003 |
|
dc.identifier.pubmed |
25420727 |
|
dc.contributor.department |
SE/AOK/I/Orvosi Vegytani, Molekuláris Biológiai és Patobiokémiai Intézet |
|
dc.contributor.institution |
Semmelweis Egyetem |
|